Scopus Biopharma, Inc.

Scopus Biopharma, Inc.

Scopus Biopharma, Inc.


420 Lexington Avenue,Suite 300,New York, NY 10170

Type of Company


Employees (Worldwide)



Medical Support Services
Retail: Other

Company Description

Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis. The company was founded on April 18, 2017 and is headquartered in New York, NY.

Executives & Employees


Director & Senior Advisor


Vice Chairman, Secretary & Treasurer

Board of Directors

Co-Chairman at Scopus Biopharma, Inc.

Director & Principal at Lipella Pharmaceuticals, Inc.

Medical Venture Partner at OurCrowd Management Ltd.

Head, Life Sciences & Healthcare Practice at Cappello Global LLC

Founder at Weild & Co., Inc.

Former Chief Financial Officer at Inform, Inc. (Georgia)

Chief Executive Officer at Triphase Accelerator Corp.

Partner at Blank Rome LLP

Vice Chairman, Secretary & Treasurer at Scopus Biopharma, Inc.

Director at PAVmed, Inc.

Paths to Scopus Biopharma, Inc.
Potential Connections via
Relationship Science
Scopus Biopharma, Inc.
Recent Transactions
Details Hidden

Scopus Biopharma, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Total Debt
Total Equity
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Scopus Biopharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Scopus Biopharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Scopus Biopharma, Inc..